Biotech entity
pharma is the sole category represented across all 1 tracked stories. LOTTE Biologics is most often covered alongside Bristol Myers Squibb, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention LOTTE Biologics, all published on March 9, 2026.
Last mentioned: Mar 9, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. LOTTE Biologics is most often covered alongside Bristol Myers Squibb, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention LOTTE Biologics, all published on March 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering LOTTE Biologics. Shared-story counts are live from our verified record — not editorial picks.
LOTTE Biologics is set to engage with global pharmaceutical leaders at DCAT Week 2026 in New York, aiming to secure strategic partnerships and showcase its expanding CDMO capabilities. The move underscores the company's aggressive push to become a top-tier global contract manufacturer by leveraging its Syracuse and Songdo facilities.
LOTTE Biologics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
